OraSure Technologies

Together with its wholly owned subsidiaries OTIprovides its customers with end-to-end solutions.Its first-to-market innovative products include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick platform; sample self-collection and stabilization p

Together with its wholly owned subsidiaries OTIprovides its customers with end-to-end solutions.Its first-to-market innovative products include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick platform; sample self-collection and stabilization p

Together with its wholly owned subsidiaries OTIprovides its customers with end-to-end solutions.Its first-to-market innovative products include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick platform; sample self-collection and stabilization p

Together with its wholly owned subsidiaries OTIprovides its customers with end-to-end solutions.Its first-to-market innovative products include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick platform; sample self-collection and stabilization p

Together with its wholly owned subsidiaries OTIprovides its customers with end-to-end solutions.Its first-to-market innovative products include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick platform; sample self-collection and stabilization p

Together with its wholly owned subsidiaries OTIprovides its customers with end-to-end solutions.Its first-to-market innovative products include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick platform; sample self-collection and stabilization p